Qualifyze
+164%
est. 2Y upside i
Stage: early. Country: Germany
Rank
#91
Sector
Healthcare Technology
Est. Liquidity
~4Y
Data Quality
Data: MediumQualifyze offers a compelling equity opportunity with a base case of 224% upside and a bull case of 300%, driven by rapid growth and strong network effects.
Last updated: July 3, 2026
Driven by an IPO window or category leadership, the exit multiple expands to 10x forward revenue. At $58.2M ARR, the exit value is $582M, yielding 300% upside after preference (capped by stage).
Exit multiple converges to 7x, in line with public SaaS comps. Exit value of $407M yields 224% upside to common stock.
Multiple compresses to 4x due to incumbent pressure or slowing growth. Exit value of $233M yields 49% upside to common.
Preference Stack Risk
severeFunding Intensity
8380%Total preferred stock of $83.8M represents 83.8% of the $100M valuation, creating severe overhang for common stock, though strong growth mitigates downside.
Dilution Risk
lowCompany is profitable and has sufficient runway from $54M Series B, making a new raise unlikely within 24 months.
Secondary Liquidity
noneNo secondary market activity reported; liquidity expected via IPO or acquisition.
Questions to Ask at the Interview
Strategic questions based on Qualifyze's data — designed to show you've done your homework.
- 1
“How does Qualifyze's network effect defend against incumbents like Eurofins and SGS who also have large audit databases?”
- 2
“Can you explain the unit economics of the hybrid revenue model (per-audit fees vs. subscriptions) and how they scale?”
- 3
“Given the preferred stock overhang of $83.8M, how would you evaluate the risk of dilution in a down-round scenario?”
Community
Valuation Sentiment
Our model estimates +164% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.